Guardian Pharmacy Services (GRDN) Cash from Investing Activities (2023 - 2026)

Guardian Pharmacy Services has disclosed Cash from Investing Activities across 4 years of filings, most recently posting -$4.8 million for Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$4.8 million, up 14.34% year-over-year; the trailing twelve-month figure through Mar 2026 was -$31.4 million (up 2.86% YoY), and the FY2025 annual result was -$32.2 million, down 5.98% from the prior year.
• Cash from Investing Activities came in at -$4.8 million for Q1 2026 at Guardian Pharmacy Services, down from -$4.7 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$1.1 million in Q4 2023 to a low of -$13.1 million in Q2 2024.
• The 4-year median for Cash from Investing Activities is -$6.1 million (2024), against an average of -$6.9 million.
• Across the five-year window, Cash from Investing Activities tumbled 477.51% in 2024 and increased 28.89% in 2025, its largest moves.
• Guardian Pharmacy Services' Cash from Investing Activities stood at -$1.1 million in 2023, then sank by 477.51% to -$6.6 million in 2024, then climbed by 28.89% to -$4.7 million in 2025, then slipped by 0.85% to -$4.8 million in 2026.
• The last three Cash from Investing Activities figures came in at -$4.8 million (Q1 2026), -$4.7 million (Q4 2025), and -$9.0 million (Q3 2025), per Business Quant data.